SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

M D Wood; C Reavill; B Trail; A Wilson; T Stean; G A Kennett; S Lightowler; T P Blackburn; D Thomas; T L Gager

doi:10.1016/s0028-3908(01)00054-5

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

Identifier:nobleid.org/w1/20260515/659F55DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/659F55DF.svg?ark=w1%2F20260515%2F659F55DF)](https://nobleid.org/work/w1/20260515/659F55DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

Identifier:nobleid.org/w1/20260515/659F55DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/659F55DF.svg?ark=w1%2F20260515%2F659F55DF)](https://nobleid.org/work/w1/20260515/659F55DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work